0

0

0

0

0

0

0

0

0

videos | IST

Biocon Q3FY21: Here's what to expect

Mini

Stock of pharma major Biocon has risen 60 percent from its March 2020 lows. The company is scheduled to report its Q3FY21 earnings tomorrow (January 21).

Stock of pharma major Biocon has risen 60 percent from its March 2020 lows. The company is scheduled to report its Q3FY21 earnings tomorrow (January 21).
CNBC-TV18 poll suggest a revenue growth of 10 percent and margins are expected to come at around 25 percent.
Watch video for more.